Skip to main content
AKAN
NASDAQ Life Sciences

AKANDA CORP. Announces 1-for-5 Reverse Stock Split to Boost Share Price

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Pharmaceutical Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$0.558
Mkt Cap
$401.87K
52W Low
$0.416
52W High
$9.29
52W Position info
34% above low
Off High info
94% below high
Rel. Volume info
0.4× avg
Market data snapshot near publication time

AKAN sits 34% above its 52-week low of $0.416 on light trading volume (0.4× avg).

Summary

Akanda Corp. will execute a 1-for-5 reverse stock split on January 12, 2026, reducing outstanding shares from 10.1 million to 2.0 million, likely to meet exchange minimum price requirements.


Key Events · Financing and Capital Events · AKAN

  • Reverse Stock Split Announced

    Akanda Corp. will implement a 1-for-5 reverse stock split, effective January 12, 2026, to consolidate its common shares.

  • Share Count Reduction

    The split will reduce the number of outstanding common shares from approximately 10.1 million to 2.0 million.

  • Fractional Share Treatment

    No fractional shares will be issued; any shareholder entitled to a fraction will have it rounded down to the nearest whole number.

  • Likely Compliance Measure

    This action is typically taken to increase the per-share price, suggesting the company is addressing potential delisting concerns from stock exchange minimum bid price rules.


Analysis · AKAN · Life Sciences

Akanda Corp. is implementing a 1-for-5 reverse stock split, a common strategy for companies to increase their per-share price to meet minimum listing requirements, such as Nasdaq's $1.00 bid price rule. While this action will reduce the number of outstanding shares and temporarily increase the stock price, it does not alter the company's fundamental valuation or address underlying business challenges. Investors should view this as a potential signal of financial distress or difficulty in maintaining exchange compliance, which can lead to further volatility and investor uncertainty.

At the time of this filing, AKAN was trading at $0.56 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $401.9K. The 52-week trading range was $0.42 to $9.29. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

AKAN - Latest Insights

AKAN
Jun 18, 2026, 5:00 PM EDT
Filing Type: 6-K
Importance Score:
9
Price at Filing: $18.20
Real-time Price: $6.50 info
Change: -$11.70 (-64%) info
Market Cap: $5.103M info
AKAN
Jun 12, 2026, 8:00 AM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $15.35
Real-time Price: $6.50 info
Change: -$8.86 (-58%) info
Market Cap: $5.103M info
AKAN
Jun 09, 2026, 4:15 PM EDT
Filing Type: 20-F
Importance Score:
9
Price at Filing: $13.76
Real-time Price: $6.50 info
Change: -$7.27 (-53%) info
Market Cap: $5.103M info
AKAN
May 22, 2026, 4:30 PM EDT
Filing Type: 6-K
Importance Score:
9
Price at Filing: $26.38
Real-time Price: $6.50 info
Change: -$19.88 (-75%) info
Market Cap: $5.103M info
AKAN
May 22, 2026, 2:00 PM EDT
Source: TMX Newsfile
Importance Score:
8
Price at Filing: $23.75
Real-time Price: $6.50 info
Change: -$17.26 (-73%) info
Market Cap: $5.103M info